| Date | Time | Source | Headline | Symbol | Company |
| 08/09/2010 | 3:06PM | Dow Jones News | UPDATE: Gilead May Get FDA Warning Letter For Calif. Facility | NASDAQ:GILD | Gilead Sciences Inc |
| 08/09/2010 | 11:31AM | Dow Jones News | Gilead May Get FDA Warning Letter For California Facility | NASDAQ:GILD | Gilead Sciences Inc |
| 08/09/2010 | 6:21AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:GILD | Gilead Sciences Inc |
| 08/03/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for AT&T, Gilead, Devon Energy, ICICI Bank, and HCP Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 08/02/2010 | 6:07AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/30/2010 | 4:30PM | Business Wire | Gilead Closes Sale of $2.2 Billion of Convertible Senior Notes | NASDAQ:GILD | Gilead Sciences Inc |
| 07/29/2010 | 9:52AM | Marketwired | Wall Street News Alert: Breaking News: Unity Management Group -- July 29, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
| 07/27/2010 | 9:15AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/27/2010 | 8:30AM | Business Wire | Gilead Prices $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2010 | 3:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2010 | 8:30AM | PR Newswire (US) | Tibotec Pharmaceuticals Submits New Drug Application for Investigational Once-Daily HIV Treatment TMC278 to U.S. Food and Drug A | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2010 | 7:27AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/26/2010 | 7:05AM | Business Wire | Gilead to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock | NASDAQ:GILD | Gilead Sciences Inc |
| 07/22/2010 | 8:30AM | PR Newswire (US) | TMC278 Pivotal Phase 3 Clinical Trials Achieve Primary Objective | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 6:17PM | Dow Jones News | 2nd UPDATE: Gilead 2Q Profit Jumps 25%; Cuts 2010 Sales View | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 5:57PM | Dow Jones News | UPDATE: Gilead 2Q Profit Jumps 25%; Cuts 2010 Sales View | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 5:18PM | Dow Jones News | Gilead Again Cuts 2010 Product Sales View, Cites Currency Moves | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 4:54PM | Dow Jones News | Gilead 2Q Profit Jumps 25% As Sales Rise; Results Miss Views | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 4:24PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/20/2010 | 4:05PM | Business Wire | Gilead Sciences Announces Second Quarter 2010 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 07/15/2010 | 6:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/14/2010 | 7:01PM | Dow Jones News | Gilead Sues Lupin In Patent-Infringement Case Over Generic Drug | NASDAQ:GILD | Gilead Sciences Inc |
| 07/14/2010 | 6:10PM | Business Wire | Gilead Sciences Files Patent Infringement Lawsuit Against Lupin Limited | NASDAQ:GILD | Gilead Sciences Inc |
| 07/13/2010 | 5:30PM | Business Wire | Gilead Sciences to Release Second Quarter 2010 Financial Results on Tuesday, July 20, 2010 | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2010 | 2:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2010 | 2:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 07/06/2010 | 2:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 06/28/2010 | 11:52AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 06/28/2010 | 9:31AM | PR Newswire (US) | Critical Alerts for Capital One, Peabody Energy, Gilead, Discover, and Hershey Released by Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 06/25/2010 | 9:25AM | Dow Jones News | Gilead Sciences To Acquire CGI Pharmaceuticals For Up To $120 Million | NASDAQ:GILD | Gilead Sciences Inc |